Cervical cancer, primarily caused by persistent Human Papillomavirus (HPV) infection, remains a substantial health challenge globally and particularly in India, where it is a significant cause of cancer deaths among women. While early stages often present no noticeable symptoms, awareness of potential early warning signs is vital for timely intervention. Key symptoms to watch for include abnormal vaginal bleeding, such as bleeding between periods, after sexual intercourse, or post-menopause. Changes in vaginal discharge, becoming watery, bloody, or foul-smelling, are also important indicators. Persistent pelvic pain or discomfort during sexual intercourse should also be investigated. More advanced symptoms can include unexplained weight loss, fatigue, leg swelling, or difficulty with urination or bowel movements. The World Health Organization (WHO) and various health experts emphasize that cervical cancer is largely preventable through regular screenings, such as Pap tests and HPV DNA tests, and HPV vaccination. In India, the government has announced the inclusion of the HPV vaccine in the national immunization program for girls aged 9-14, with an indigenously produced vaccine (Cervavac) now available at affordable rates. January is designated as Cervical Cancer Awareness Month, aiming to educate the public on prevention and early detection. Recognizing and acting on these symptoms promptly, coupled with preventive measures, can significantly improve treatment outcomes and save lives.